Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Combining PARP inhibition with PD-1 inhibitors

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Access to radiotherapy among circumpolar Inuit populations

    Research output: Contribution to journalReviewResearchpeer-review

  1. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalLancet Oncology
Volume20
Issue number9
Pages (from-to)1196-1198
Number of pages3
ISSN1470-2045
DOIs
Publication statusPublished - Sep 2019

ID: 58970950